These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37304971)

  • 1. Extracellular Vesicles Derived circSH3PXD2A Inhibits Chemoresistance of Small Cell Lung Cancer by miR-375-3p/YAP1.
    Chao F; Zhang Y; Lv L; Wei Y; Dou X; Chang N; Yi Q; Li M
    Int J Nanomedicine; 2023; 18():2989-3006. PubMed ID: 37304971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen.
    Zhang Y; Chao F; Lv L; Li M; Shen Z
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15365-15382. PubMed ID: 37639013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.
    Hua J; Wang X; Ma L; Li J; Cao G; Zhang S; Lin W
    Mol Cancer; 2022 Jun; 21(1):123. PubMed ID: 35668527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis.
    Zhong Y; Lin H; Li Q; Liu C; Shen J
    Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling.
    Huang W; Yang Y; Wu J; Niu Y; Yao Y; Zhang J; Huang X; Liang S; Chen R; Chen S; Guo L
    Cell Death Differ; 2020 May; 27(5):1709-1727. PubMed ID: 31728016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells.
    Zhu T; Hu Z; Wang Z; Ding H; Li R; Wang J; Wang G
    Cell Biol Toxicol; 2023 Oct; 39(5):1923-1937. PubMed ID: 35246762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
    Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
    Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
    Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
    J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B.
    Qiu F; Qiao B; Zhang N; Fang Z; Feng L; Zhang S; Qiu W
    Cancer Cell Int; 2021 Aug; 21(1):412. PubMed ID: 34353342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
    Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W
    Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
    Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
    Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer.
    Ren M; Song X; Niu J; Tang G; Sun Z; Li Y; Kong F
    Exp Cell Res; 2022 Oct; 419(2):113276. PubMed ID: 35863454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
    Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
    BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
    Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
    Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway.
    Li M; Shan W; Hua Y; Chao F; Cui Y; Lv L; Dou X; Bian X; Zou J; Li H; Lin W
    Front Cell Dev Biol; 2021; 9():661602. PubMed ID: 34136482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.